We're proud to receive a 2025 CDMO Leadership Award in the “Small Molecule Dosage Form - Global" category.
With the rapid expansion of the cell and gene therapy market, innovators will require reliable supply chain solutions to enable the safe and efficient transportation of products to patients in need.
The following article highlights several industry challenges and key consideration as clients prepare for commercialization of advanced therapy products, including: